Please try another search
Name | Last | High | Low | Chg. | Chg. % | Vol. | Time | ||
---|---|---|---|---|---|---|---|---|---|
AddLife | 104.00 | 104.00 | 100.80 | +1.60 | +1.56% | 18.48K | 11:54:50 | ||
Arjo | 46.72 | 47.36 | 46.66 | -0.18 | -0.38% | 209.65K | 11:59:57 | ||
Bactiguard Holding AB | 70.80 | 72.00 | 67.00 | +1.20 | +1.72% | 2.52K | 11:59:39 | ||
BICO Group | 46.30 | 48.48 | 46.30 | -1.70 | -3.54% | 47.62K | 11:59:49 | ||
Boule Diagnostics | 10.05 | 10.15 | 10.00 | -0.05 | -0.50% | 1.55K | 11:28:10 | ||
C-Rad | 39.45 | 39.55 | 38.20 | +0.95 | +2.47% | 18.35K | 11:59:40 | ||
CellaVision AB | 225.00 | 227.50 | 223.50 | -2.50 | -1.10% | 4.10K | 11:48:57 | ||
Elekta B | 79.20 | 79.45 | 78.65 | +0.20 | +0.25% | 108.03K | 11:59:57 | ||
Episurf Medical AB | 0.36 | 0.37 | 0.36 | -0.01 | -3.07% | 151.35K | 11:59:30 | ||
Getinge B | 235.9 | 239.7 | 235.0 | -3.6 | -1.50% | 192.58K | 11:54:55 | ||
Immunovia publ AB | 2.03 | 2.17 | 2.01 | -0.14 | -6.24% | 287.12K | 11:59:40 | ||
Ortivus A | 4.480 | 4.580 | 4.040 | 0.000 | 0.00% | 0 | 11:59:34 | ||
Ortivus B | 2.560 | 2.560 | 2.510 | +0.010 | +0.39% | 5.44K | 11:35:48 | ||
Q linea | 2.60 | 3.00 | 2.51 | -0.32 | -10.82% | 750.67K | 11:59:43 | ||
RaySearch Labs B | 120.60 | 120.60 | 117.00 | +1.40 | +1.17% | 28.38K | 11:59:41 | ||
Sectra | 219.20 | 224.00 | 217.80 | -3.40 | -1.53% | 23.81K | 11:59:45 | ||
Sedana Medical | 22.45 | 22.75 | 20.85 | +1.35 | +6.40% | 169.72K | 11:54:59 | ||
Senzime | 7.0500 | 7.3900 | 6.7900 | -0.0600 | -0.84% | 272.64K | 11:54:07 | ||
Vitrolife | 167.30 | 169.60 | 165.10 | -0.40 | -0.24% | 22.02K | 11:54:55 | ||
Xvivo Perfusion AB | 379.00 | 385.00 | 373.50 | +2.00 | +0.53% | 30.63K | 11:59:52 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review